Methyl 4-(bromomethyl)-2,5-difluorobenzoate, 97.0%, 250mg

2-(2-Methyl-imidazol-1-yl)-phenylamine, 250mg

N-(3-bromopropyl)-N-butylbutan-1-amine hydrobromide, 95.0%, 1g

Fmoc-L-Ornithine-(Boc), PEPTIPURE®, min 98%, pour la biochimie, 10 g, emballage plastique.

Dapoxetine hydrochloride, 95.0%, 25g

4-Iodo-cyclohexylamine hydrochloride, 95.0%, 250mg

1-tert-Butoxycarbonyl-4-(cyclopropylamino)piperidine, 95.0%, 250mg

2-Bromo-5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one, 95.0%, 250mg

ETHYL 3-OXOTETRAHYDRO-2H-PYRAN-4-CARBOXYLATE, 95.0%, 5g

Dimethyl 3-Nitrophthalate>99.0%(GC)5g

Methyl 4-methoxy-3,5-dimethylpicolinate, 95+%, 1g

2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane>95.0%(GC)25g

[(5-methyl-1H-benzimidazol-2-yl)methyl]amine dihydrochloride, 95.0%, 25g